Cover Image
市場調查報告書

血液檢驗:各種技術和全球市場

Blood Testing: Technology and Global Markets

出版商 BCC Research 商品編碼 327448
出版日期 內容資訊 英文 168 Pages
訂單完成後即時交付
價格
Back to Top
血液檢驗:各種技術和全球市場 Blood Testing: Technology and Global Markets
出版日期: 2015年03月30日 內容資訊: 英文 168 Pages
簡介

血液檢驗的市場2013年記錄為495億美元,2014年為500億美元的規模。從2014年到2019年預計以2.6%的年複合成長率發展,2019年成長到566億美元的規模。

本報告提供全球血液檢驗的市場相關調查、血液檢驗的各種目的與檢查項目、相關的法律規章、新的開發及市場發展趨勢、檢驗內容、地區、利用地方等各種各市場收益的變化與預測、市場領導與市場佔有率、市場的影響因素分析、專利趨勢,以及主要企業的簡介等彙整。

第1章 簡介

第2章 摘要

第3章 概要

第3章 概要

  • 定義
  • 血液檢驗的發展的過程
  • 檢驗
    • 傳統檢驗
    • 就地檢驗 (POC檢驗)
  • 血液檢驗
  • 診斷檢驗
    • 血液常規檢查
    • 紅血球沉澱速度 (ESR)
    • 酵素檢驗
    • 血液凝固檢驗
    • 動脈血氣檢驗 (ABG檢驗)
  • 篩檢面板
    • 篩檢試驗
    • 癌症篩檢血液檢驗/癌症生物標記檢驗
    • 血型檢驗及交叉配對試驗
    • 蛋白實驗
    • 一般毒性、藥物濫用檢測
    • 脂質簡介或膽固醇檢驗
    • 綜合代謝面板
  • 監測檢驗
    • 遺傳基因檢驗
    • 生物化學檢驗 或BMP
    • 荷爾蒙檢驗
  • 血液檢驗的血液抽取方法
  • 血液檢驗的優點
  • 血液檢驗的缺點
  • 就地檢驗的技術性展望
    • PCR
    • 串聯型質譜分析
    • 微陣列
    • 遺傳基因序列測定或DNA序列測定
    • FISH法

第4章 法律制度

  • 免除CLIA (臨床檢驗改善促進法) 的檢驗

第5章 新的開發、發展趨勢

  • 血液檢驗、化驗、套件的臨床試驗
  • M&A
  • 新產品的市場投入
  • 新技術

第6章 市場分析

  • 各類型市場
    • 市場概要
    • 市場收益
    • 市場佔有率
  • 各地區市場
    • 市場概要
    • 市場收益
    • 市場佔有率
    • 血液學性檢驗
      • 市場概要
      • 市場收益
    • 傳染病檢查
      • 市場概要
      • 市場收益
    • 血液凝固檢查
      • 市場概要
      • 市場收益
    • 血液常規檢查、綜合血液檢驗、酵素血液檢驗
      • 市場概要
      • 市場收益
    • 癌症檢查 (腫瘤/癌症化驗試驗)
      • 市場概要
      • 市場收益
    • 毒性檢驗
      • 市場概要
      • 市場收益
    • 心臟簡介的檢驗
      • 市場概要
      • 市場收益
    • 發炎的檢驗
      • 市場概要
      • 市場收益
    • 其他
      • 市場概要
      • 市場收益

第7章 產業結構

  • 血液學
    • 市場領導
    • 市場佔有率
  • 心臟
    • 市場佔有率
  • 發炎
    • 市場領導
    • 市場佔有率
  • 癌症
    • 市場領導
    • 市場佔有率
  • 毒素
    • 市場領導
    • 市場佔有率
  • 其他
    • 市場領導
    • 市場佔有率

第8章 血液檢驗市場:各利用場所

  • 各血液檢驗的利用場所的市場
    • 全球市場:各利用場所
    • 市場佔有率
  • 處方/醫生辦公室/診療所的血液檢驗
    • 市場概要
    • 市場收益
    • 市場佔有率
    • 癌症血液檢驗
      • 癌症生物標記
      • 市場概要
      • 市場收益
  • 血液疾病檢驗
    • 市場概要
    • 市場收益
  • 自體免疫疾病 、食物過敏的檢驗
    • 市場概要
    • 市場收益
  • 心血管疾病檢驗
    • 市場概要
    • 市場收益
  • 腎障礙檢驗
    • 市場概要
    • 市場收益
  • 肝損傷檢驗
    • 市場概要
    • 市場收益
  • 妊娠檢驗
    • 市場概要
    • 市場收益
  • 糖尿病檢驗
    • 市場概要
    • 市場收益
  • 妊娠能力檢驗
    • 市場概要
    • 市場收益
  • 家用監測檢驗
    • 市場概要
    • 市場收益
    • 市場佔有率
    • 設備
      • 市場概要
      • 市場收益
    • 試驗帶
      • 市場概要
      • 市場收益

第9章 專利分析

  • 各年代
  • 各類型/類別
  • 各企業
  • 各國
  • 各申請人

第10章 目前情形

  • 血液檢驗的因素
    • 慢性疾病、感染疾病
    • 高齡化
    • 生活方式
    • 肥胖
    • 家用監控系統、新產品
    • 製造技術
    • 價格控制
    • 法律規章上的壓力
    • 同類的設備
    • 授權契約
    • M&A

第11章 企業簡介

  • A. MENARINI DIAGNOSTICS LTD.
  • ABAXIS
  • ABBOTT LABORATORIES
  • AKERS BIOSCIENCES INC. (ABI)
  • ALERE INC.
  • ANDON HEALTH CO. LTD.
  • APEX BIOTECHNOLOGY CORP.
  • ARKRAY USA INC.
  • BAYER HEALTHCARE PHARMACEUTICALS
  • BECTON, DICKINSON AND CO. (BD)
  • BIOMERIEUX MARCY L'ETOILE
  • BIO-RAD LABORATORIES INC.
  • CEPHEID
  • DANAHER CORP.
  • DEXCOM INC.
  • GRIFOLS
  • HEMOSENSE INC.
  • HMD BIOMEDICAL INC.
  • HOFFMAN-LA ROCHE
  • HOLOGIC
  • IDEAL LIFE INC.
  • INFOPIA CO. LTD.
  • JOHNSON & JOHNSON
  • LIFESCAN INC.
  • LUMINEX CORP.
  • MEDTRONIC
  • NIPRO DIAGNOSTICS INC.
  • NOVA BIOMEDICAL CORP.
  • ORTHO CLINICAL DIAGNOSTICS
  • QIAGEN
  • SIEMENS AG
  • T2 BIOSYSTEMS
  • THERMO FISHER SCIENTIFIC INC.
  • TRINITY BIOTECH

第12章 附錄

圖表

目錄
Product Code: HLC184A

REPORT HIGHLIGHTS

The blood testing market totaled $49.5 billion in 2013 and reached to nearly $50 billion in 2014 This market is expected to grow $56.6 billion in 2019, with a compound annual growth rate (CAGR) of 2.6%.

This report provides:

  • An overview of the global markets and technologies for blood testing.
  • Analyses of global market trends, with data from 2012, 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
  • Coverage of major blood test categories including hematology, molecular screening, toxicology, and also oncology biomarker tests and cardiology tests.
  • Information on the latest trends and innovations in the blood testing product pipeline as well as information on new approaches for screening.
  • Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities.
  • Relevant patent analysis.
  • Profiles of major players in the blood testing market.

SCOPE OF THE STUDY

This study covers the blood tests that are used routinely for screening, monitoring and evaluating by using analyzers (including automated analyzers) and integrated systems. This report also covers home-monitoring devices and test strips and the associated calibration reagents. The report analyzes and assesses therapeutic and screening applications of blood tests for human conditions such as diabetes, heart disease, autoimmune disorders, cancer, blood disorders, hormonal imbalances, infection, and pregnancy. Excluded from this study are urinalysis, urine home diagnostic kits, and diagnostic testing such as imaging. This study also excludes veterinary blood tests and their analyzers.

The scope of this study is global. BCC Research analyzes each market and its applications, regulatory environment, technologies involved, market projections, and market shares. The emerging markets discussed include countries such as India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand, and Canada, among others. The Europe and U.S. markets are also covered.

The report also examines the factors boosting the blood testing market as well as the hindering factors. Further, the pipeline products and companies that are leading the blood test diagnostic market in the research and development of blood tests are discussed.

ANALYSTS' CREDENTIALS

This study has been carried out by a team of professionals in the biotechnology industry. The project manager for this project is Shalini S. Dewan, who holds a master's degree in pharmaceutical chemistry and has over 14 years of industry experience. Ms. Dewan was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • CONTRIBUTIONS OF THE STUDY AND FOR WHOM
  • SCOPE OF THE STUDY
  • METHODOLOGY
  • INFORMATION SOURCES
  • ANALYSTS' CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - EXECUTIVE SUMMARY

  • SUMMARY TABLE: GLOBAL REVENUE FOR BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL REVENUE FOR BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)

CHAPTER 3 - OVERVIEW

  • DEFINITIONS
    • BLOOD TEST
    • ANTIGEN
    • ANTIBODY
    • RED BLOOD CELLS
    • WHITE BLOOD CELLS
    • PLATELETS
    • PLASMA
    • BLOOD GROUP OR BLOOD TYPE
    • BLOOD TRANSFUSION
  • HISTORY OF BLOOD TESTING
    • TABLE 1: EVOLUTION OF BLOOD TRANSFUSION AND BLOOD TESTS
  • TESTING
    • TRADITIONAL TESTING
    • POINT-OF-CARE (POC) TESTING
      • TABLE 2: DIFFERENCES BETWEEN TRADITIONAL (MANUAL) BLOOD TESTING AND POINT-OF-CARE TESTING (AUTOMATIC)
  • BLOOD TESTS
  • DIAGNOSTIC TESTS
    • COMPLETE BLOOD COUNT
      • Total Red Blood Cell Count
      • Total White Blood Cell Count
      • Mean Corpuscular Volume (MCV)
      • Hemoglobin
      • Hematocrit
      • Hemoglobin A1c (HbA1c)
      • Mean Corpuscular Hemoglobin or Mean Corpuscular Hemoglobin Volume
    • COMPLETE BLOOD COUNT WITH DIFFERENTIAL AND PLATELET BLOOD TEST
      • Neutrophil Granulocytes
      • Lymphocytes
      • Monocytes
      • Eosinophil Granulocytes
      • Basophil Granulocytes
      • Platelets
        • TABLE 3: CONDITIONS ASSOCIATED WITH ABNORMALITIES OF ANALYTE OF COMPLETE BLOOD COUNT
    • ERYTHROCYTE SEDIMENTATION RATE (ESR)
    • ENZYME TEST
      • Troponin
      • Creatine Kinase (CK)
      • Lactate Dehydrogenase (LDH)
      • Alanine Transaminase (ALT) and Aspartate Transaminase (AST)
    • CLOTTING TEST OR COAGULATION TEST
      • Hemostasis
      • Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT)
      • Factor V Assay
      • Fibrinogen
      • Thrombin Time
    • ARTERIAL BLOOD GAS (ABG) TEST
  • SCREENING PANELS
    • SCREENING TESTS
    • CANCER SCREENING BLOOD TEST/CANCER BIOMARKER TEST
    • BLOOD GROUPING OR CROSS-MATCHING TEST
      • TABLE 4: BLOOD GROUP COMPATIBILITY
      • TABLE 5: PLASMA COMPATIBILITY
    • TOTAL PROTEIN TEST
      • A/G (Albumin/Globulin)
      • Total Bilirubin
    • GENERAL TOXICOLOGY AND DRUG-ABUSE TEST
      • Biomonitoring or Body Burden Test
      • Food Safe Allergy Test/Panel
    • LIPID PROFILE OR CHOLESTEROL TEST
      • Cholesterol Test
        • Cholesterol
      • C-Reactive Protein Test
    • COMPREHENSIVE METABOLIC PANEL
  • MONITORING TESTS
    • GENETIC TEST
    • BIOCHEMICAL TEST OR BASIC METABOLIC PANEL (BMP)
      • Diabetic Profile
      • Fluids and Electrolytes
      • Calcium
      • Kidney Profile
    • HORMONE TEST
  • METHODS OF EXTRACTION OF BLOOD FOR BLOOD TESTING
  • ADVANTAGES OF BLOOD TESTS
  • DISADVANTAGES OF BLOOD TESTS
  • TECHNOLOGY OUTLOOK FOR POINT-OF-CARE TESTING
    • POLYMERASE CHAIN REACTION (PCR)
    • TANDEM MASS SPECTROMETRY
    • MICROARRAY
    • GENE SEQUENCING OR DNA SEQUENCING
    • FLUORESCENCE IN SITU HYBRIDIZATION (FISH)

CHAPTER 4 - REGULATORY ASPECTS

  • CLIA-WAIVED TESTS
    • RECENTLY APPROVED BLOOD TESTS, ASSAYS, KITS, AND DEVICES
      • TABLE 6: RECENT APPROVALS OF BLOOD TESTS, ASSAYS, KITS, AND MEDICAL DEVICES, 2010 TO SEPTEMBER 2014
    • RECENT APPROVALS OF MEDICAL DEVICES CLEARED THROUGH 510(K)
      • TABLE 7: RECENT APPROVALS OF MEDICAL DEVICES CLEARED THROUGH 510(K), 2010 TO SEPTEMBER 2014
    • APPROVALS OF CLIA-WAIVED BLOOD TESTS
      • TABLE 8: APPROVALS OF CLIA-WAIVED BLOOD TESTS, 2010 TO SEPTEMBER 2014
    • RECALLS
      • TABLE 9: RECALLS,2010 TO SEPTEMBER 2014
    • SAFETY ALERTS
      • TABLE 10: SAFETY ALERTS, 2010 TO SEPTEMBER 2014

CHAPTER 5 - NEW DEVELOPMENTS

  • CLINICAL TRIALS OF BLOOD TESTS, ASSAYS AND KITS
    • TABLE 11: CLINICAL TRIALS IN BLOOD TESTS, ASSAYS AND KITS, 2010 TO SEPTEMBER 2014
  • MERGERS AND ACQUISITIONS
    • TABLE 12: MERGERS AND ACQUISITIONS OF TOP PHARMACEUTICAL COMPANIES, 2010 TO SEPTEMBER 2014
  • NEW PRODUCT LAUNCHES
    • TABLE 13: NEW PRODUCT LAUNCHES, 2012 TO SEPTEMBER 2014
  • NEW TECHNOLOGIES

CHAPTER 6 - MARKET ANALYSIS

  • MARKET BY TYPE
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 14: GLOBAL REVENUE FOR BLOOD TESTS BY TYPE, THROUGH 2019
      • FIGURE 1: GLOBAL REVENUE FOR BLOOD TESTS BY TYPE, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 15: MARKET SHARE OF BLOOD TESTS BY TYPE, 2013 (%)
      • FIGURE 2: MARKET SHARE OF BLOOD TESTS BY TYPE, 2013 (%)
  • MARKET BY REGION
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 16: GLOBAL REVENUE FOR BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 3: GLOBAL REVENUE FOR BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 17: MARKET SHARE OF BLOOD TESTS BY REGION, 2013 (%)
      • FIGURE 4: MARKET SHARE OF BLOOD TESTS BY REGION, 2013 (%)
    • HEMATOLOGY BLOOD TESTS
      • Market Overview
      • Market Revenue
        • TABLE 18: GLOBAL REVENUE FOR HEMATOLOGY BLOOD TESTS BY TYPE, THROUGH 2019 ($ MILLIONS)
        • FIGURE 5: GLOBAL REVENUE FOR HEMATOLOGY BLOOD TESTS BY TYPE, 2012-2019 ($ MILLIONS)
    • Infectious Blood Tests
      • Market Overview
      • Market Revenue
        • TABLE 19: GLOBAL REVENUE FOR INFECTIOUS BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 6: GLOBAL REVENUE FOR INFECTIOUS BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • Blood Clotting Tests
      • Market Overview
      • Market Revenue
        • TABLE 20: GLOBAL REVENUE FOR BLOOD CLOTTING TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 7: GLOBAL REVENUE FOR BLOOD CLOTTING TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • Complete Blood Count, Comprehensive Blood Tests, and Enzyme Blood Tests
      • Market Overview
      • Market Revenue
        • TABLE 21: GLOBAL REVENUE FOR COMPLETE BLOOD COUNT, COMPREHENSIVE BLOOD TESTS, AND ENZYME BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 8: GLOBAL REVENUE FOR COMPLETE BLOOD COUNT, COMPREHENSIVE BLOOD TESTS, AND ENZYME BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • ONCOLOGY BLOOD TESTS (TUMOR/CANCER ASSAY TESTS)
      • Market Overview
      • Market Revenue
        • TABLE 22: GLOBAL REVENUE FOR CANCER/TUMOR ASSAY TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 9: GLOBAL REVENUE FOR CANCER/TUMOR ASSAY TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • TOXICOLOGY BLOOD TESTS
      • Market Overview
      • Market Revenue
        • TABLE 23: GLOBAL REVENUE FOR TOXICOLOGY TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 10: GLOBAL REVENUE FOR TOXICOLOGY TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • HEART PROFILE BLOOD TESTS
      • Market Overview
      • Market Revenue
        • TABLE 24: GLOBAL REVENUE FOR HEART PROFILE BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 11: GLOBAL REVENUE FOR HEART PROFILE BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • INFLAMMATION BLOOD TESTS
      • Market Overview
      • Market Revenue
        • TABLE 25: GLOBAL REVENUE FOR INFLAMMATION BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 12: GLOBAL REVENUE FOR INFLAMMATION BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • OTHERS CATEGORY OF BLOOD TESTS
      • Market Overview
      • Market Revenue
        • TABLE 26: GLOBAL REVENUE FOR OTHER BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 13: GLOBAL REVENUE FOR OTHER BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)

CHAPTER 7 - INDUSTRY STRUCTURE

  • HEMATOLOGY
    • MARKET LEADERS
      • TABLE 27: LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN HEMATOLOGY BLOOD TESTING, 2013
  • MARKET SHARE
    • TABLE 28: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEMATOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • FIGURE 14: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEMATOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
  • HEART PROFILE
    • MARKET LEADERS
      • TABLE 29: LEADING MANUFACTURERS/ SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN HEART PROFILE BLOOD TESTING, 2013
    • MARKET SHARE
      • TABLE 30: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEART PROFILE BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013
      • FIGURE 15: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEART PROFILE BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
  • INFLAMMATION
    • MARKET LEADERS
      • TABLE 31: LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN INFLAMMATION BLOOD TESTING, 2013
  • MARKET SHARE
    • TABLE 32: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF INFLAMMATION BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • FIGURE 16: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF INFLAMMATION BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
  • ONCOLOGY
    • MARKET LEADERS
      • TABLE 33: LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN ONCOLOGY BLOOD TESTING, 2013
    • MARKET SHARE
      • TABLE 34: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF ONCOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
      • FIGURE 17: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF ONCOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
  • TOXICOLOGY
    • MARKET LEADERS
      • TABLE 35: LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN TOXICOLOGY BLOOD TESTING, 2013
    • MARKET SHARE
      • TABLE 36: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF TOXICOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013
      • FIGURE 18: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF TOXICOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
  • OTHERS CATEGORY
    • MARKET LEADERS
      • TABLE 37: LEADING MANUFACTURERS/SUPPLIERS OF DEVICES, TEST STRIPS, AND ASSAYS IN OTHERS CATEGORY OF BLOOD TESTING, 2013
    • MARKET SHARE
      • TABLE 38: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THE OTHERS CATEGORY OF BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
      • FIGURE 19: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THE OTHERS CATEGORY OF BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)

CHAPTER 8 - MARKET BY APPLICATION

  • BLOOD TESTS BY APPLICATION
    • GLOBAL BLOOD TESTING MARKET BY APPLICATION
      • TABLE 39: GLOBAL REVENUE FOR BLOOD TESTS BY APPLICATION AND END USER, THROUGH 2019 ($ MILLIONS)
      • FIGURE 20: GLOBAL REVENUE FOR BLOOD TESTS BY APPLICATION AND END USER, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 40: MARKET SHARE OF BLOOD TESTS BY APPLICATION AND END USER, 2013 (%)
      • FIGURE 21: MARKET SHARE OF BLOOD TESTS BY APPLICATION AND END USER, 2013 (%)
  • PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 41: GLOBAL REVENUE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, THROUGH 2019 ($ MILLIONS)
      • FIGURE 22: GLOBAL REVENUE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 42: MARKET SHARE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, 2013 (%)
      • FIGURE 23: MARKET SHARE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, 2013 (%)
    • CANCER BLOOD TESTING
      • TABLE 43: DIFFERENT KINDS OF CANCER
      • Cancer Biomarker
        • TABLE 44: CANCER BIOMARKERS
      • Market Overview
      • Market Revenue
        • TABLE 45: GLOBAL REVENUE FOR CANCER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 24: GLOBAL REVENUE FOR CANCER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
  • BLOOD DISORDER BLOOD TESTING
    • TABLE 46: BLOOD DISORDERS
    • Market Overview
    • Market Revenue
      • TABLE 47: GLOBAL REVENUE FOR BLOOD DISORDER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 25: GLOBAL REVENUE FOR BLOOD DISORDER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
  • AUTOIMMUNE DISEASE AND FOOD ALLERGY TESTING
    • TABLE 48: AUTOIMMUNE DISEASES
    • Market Overview
    • Market Revenue
      • TABLE 49: GLOBAL REVENUE FOR AUTOIMMUNE DISEASE BLOOD TESTING AND FOOD ALLERGY BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 26: GLOBAL REVENUE FOR AUTOIMMUNE DISEASE BLOOD TESTING AND FOOD ALLERGY BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
  • CARDIOVASCULAR DISEASE BLOOD TESTING
    • TABLE 50: CARDIOVASCULAR DISEASES
    • Market Overview
    • Market Revenue
      • TABLE 51: GLOBAL REVENUE FOR CARDIOVASCULAR DISEASE BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 27: GLOBAL REVENUE FOR CARDIOVASCULAR DISEASE BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
  • KIDNEY DISORDER BLOOD TESTING
    • TABLE 52: KIDNEY DISORDERS
    • Market Overview
    • Market Revenue
      • TABLE 53: GLOBAL REVENUE FOR KIDNEY DISORDER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 28: GLOBAL REVENUE FOR KIDNEY DISORDER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
  • LIVER DISORDER BLOOD TESTING
    • Market Overview
    • Market Revenue
      • TABLE 54: GLOBAL REVENUE FOR LIVER DISORDER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 29: GLOBAL REVENUE FOR LIVER DISORDER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
  • PREGNANCY BLOOD TESTING
    • TABLE 55: INFECTIONS CAUSED BY MICROORGANISMS
    • Market Overview
    • Market Revenue
      • TABLE 56: GLOBAL REVENUE FOR PREGNANCY BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 30: GLOBAL REVENUE FOR PREGNANCY BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
  • DIABETES BLOOD TESTING
    • TABLE 57: TYPES OF DIABETES
    • Market Overview
    • Market Revenue
      • TABLE 58: GLOBAL REVENUE FOR DIABETES BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 31: GLOBAL REVENUE FOR DIABETES BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
  • FERTILITY BLOOD TESTING
    • Market Overview
    • Market Revenue
      • TABLE 59: GLOBAL REVENUE FOR FERTILITY BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 32: GLOBAL REVENUE FOR FERTILITY BLOOD TESTS, BY REGION, 2012-2019 ($ MILLIONS)
  • HOME-MONITORING BLOOD TESTING
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 60: GLOBAL REVENUE FOR HOME-MONITORING BLOOD TESTING, THROUGH 2019 ($ MILLIONS)
      • FIGURE 33: GLOBAL REVENUE FOR HOME-MONITORING BLOOD TESTING, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 61: MARKET SHARE OF HOME-MONITORING BLOOD TESTING, 2013 (%)
      • FIGURE 34: MARKET SHARE OF HOME-MONITORING BLOOD TESTING, 2013 (%)
    • DEVICES
      • TABLE 62: HOME-MONITORING DEVICES
      • Market Overview
      • Market Revenue
        • TABLE 63: GLOBAL REVENUE FOR HOME-MONITORING DEVICES BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 35: GLOBAL REVENUE FOR HOME-MONITORING DEVICES BY REGION, 2012-2019 ($ MILLIONS)
    • TEST STRIPS
      • Market Overview
      • Market Revenue
        • TABLE 64: GLOBAL REVENUE FOR HOME-MONITORING TEST STRIPS BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 36: GLOBAL REVENUE FOR HOME-MONITORING TEST STRIPS BY REGION, 2012-2019 ($ MILLIONS)

CHAPTER 9 - PATENT ANALYSIS

  • PATENTS BY YEAR
    • TABLE 65: NUMBER OF SIGNIFICANT PATENTS BY YEAR, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • FIGURE 37: NUMBER OF SIGNIFICANT PATENTS BY YEAR, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
  • PATENTS BY TYPE/CATEGORY
    • TABLE 66: NUMBER OF SIGNIFICANT PATENTS BY CATEGORY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • FIGURE 38: NUMBER OF SIGNIFICANT PATENTS BY CATEGORY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
  • PATENTS BY COMPANY
    • TABLE 67: NUMBER OF U.S. PATENTS BY COMPANY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
  • PATENTS BY COUNTRY
    • TABLE 68: NUMBER OF U.S. PATENTS BY COUNTRY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • TABLE 69: PATENT SHARES BY COUNTRY, JANUARY 2010 TO SEPTEMBER 2014 (%)
  • PATENTS BY ASSIGNEE
    • TABLE 70: NUMBER OF U.S. PATENTS BY ASSIGNEE, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • FIGURE 39: NUMBER OF U.S. PATENTS BY ASSIGNEE, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)

CHAPTER 10 - CURRENT SITUATION

  • FACTORS AFFECTING BLOOD TESTING
    • THE IMPACT OF CHRONIC DISEASES AND INFECTIONS
    • THE IMPACT OF THE AGING POPULATION
    • THE IMPACT OF LIFESTYLE
    • THE IMPACT OF OBESITY
    • THE IMPACT OF HOME-MONITORING SYSTEMS AND NEW PRODUCTS
    • THE IMPACT OF MANUFACTURING TECHNOLOGIES
    • THE IMPACT OF PRICE CONTROLS
    • THE IMPACT OF REGULATORY PRESSURES
    • THE IMPACT OF SIMILAR DEVICES
    • THE IMPACT OF LICENSING AGREEMENTS
    • THE IMPACT OF MERGERS AND ACQUISITIONS

CHAPTER 11 - COMPANY PROFILES

  • A. MENARINI DIAGNOSTICS LTD.
  • ABAXIS
  • ABBOTT LABORATORIES
  • AKERS BIOSCIENCES INC. (ABI)
  • ALERE INC.
  • ANDON HEALTH CO. LTD.
  • APEX BIOTECHNOLOGY CORP.
  • ARKRAY USA INC.
  • BAYER HEALTHCARE PHARMACEUTICALS
  • BECTON, DICKINSON AND CO. (BD)
  • BIOMERIEUX MARCY L'ETOILE
  • BIO-RAD LABORATORIES INC.
  • CEPHEID
  • DANAHER CORP.
  • DEXCOM INC.
  • GRIFOLS
  • HEMOSENSE INC.
  • HMD BIOMEDICAL INC.
  • HOFFMAN-LA ROCHE
  • HOLOGIC
  • IDEAL LIFE INC.
  • INFOPIA CO. LTD.
  • JOHNSON & JOHNSON
  • LIFESCAN INC.
  • LUMINEX CORP.
  • MEDTRONIC
  • NIPRO DIAGNOSTICS INC.
  • NOVA BIOMEDICAL CORP.
  • ORTHO CLINICAL DIAGNOSTICS
  • QIAGEN
  • SIEMENS AG
  • T2 BIOSYSTEMS
  • THERMO FISHER SCIENTIFIC INC.
  • TRINITY BIOTECH

CHAPTER 12 - APPENDIX-ABBREVIATIONS

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL REVENUE FOR BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 1: EVOLUTION OF BLOOD TRANSFUSION AND BLOOD TESTS
    • TABLE 2: DIFFERENCES BETWEEN TRADITIONAL (MANUAL) BLOOD TESTING AND POINT-OF-CARE TESTING (AUTOMATIC)
    • TABLE 3: CONDITIONS ASSOCIATED WITH ABNORMALITIES OF ANALYTE OF COMPLETE BLOOD COUNT
    • TABLE 4: BLOOD GROUP COMPATIBILITY
    • TABLE 5: PLASMA COMPATIBILITY
    • TABLE 6: RECENT APPROVALS OF BLOOD TESTS, ASSAYS, KITS, AND MEDICAL DEVICES, 2010 TO SEPTEMBER 2014
    • TABLE 7: RECENT APPROVALS OF MEDICAL DEVICES CLEARED THROUGH 510(K), 2010 TO SEPTEMBER 2014
    • TABLE 8: APPROVALS OF CLIA-WAIVED BLOOD TESTS, 2010 TO SEPTEMBER 2014
    • TABLE 9: RECALLS,2010 TO SEPTEMBER 2014
    • TABLE 10: SAFETY ALERTS, 2010 TO SEPTEMBER 2014
    • TABLE 11: CLINICAL TRIALS IN BLOOD TESTS, ASSAYS AND KITS, 2010 TO SEPTEMBER 2014
    • TABLE 12: MERGERS AND ACQUISITIONS OF TOP PHARMACEUTICAL COMPANIES, 2010 TO SEPTEMBER 2014
    • TABLE 13: NEW PRODUCT LAUNCHES, 2012 TO SEPTEMBER 2014
    • TABLE 14: GLOBAL REVENUE FOR BLOOD TESTS BY TYPE, THROUGH 2019
    • TABLE 15: MARKET SHARE OF BLOOD TESTS BY TYPE, 2013 (%)
    • TABLE 16: GLOBAL REVENUE FOR BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 17: MARKET SHARE OF BLOOD TESTS BY REGION, 2013 (%)
    • TABLE 18: GLOBAL REVENUE FOR HEMATOLOGY BLOOD TESTS BY TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 19: GLOBAL REVENUE FOR INFECTIOUS BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 20: GLOBAL REVENUE FOR BLOOD CLOTTING TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 21: GLOBAL REVENUE FOR COMPLETE BLOOD COUNT, COMPREHENSIVE BLOOD TESTS, AND ENZYME BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 22: GLOBAL REVENUE FOR CANCER/TUMOR ASSAY TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 23: GLOBAL REVENUE FOR TOXICOLOGY TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 24: GLOBAL REVENUE FOR HEART PROFILE BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 25: GLOBAL REVENUE FOR INFLAMMATION BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 26: GLOBAL REVENUE FOR OTHER BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 27: LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN HEMATOLOGY BLOOD TESTING, 2013
    • TABLE 28: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEMATOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • TABLE 29: LEADING MANUFACTURERS/ SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN HEART PROFILE BLOOD TESTING, 2013
    • TABLE 30: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEART PROFILE BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013
    • TABLE 31: LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN INFLAMMATION BLOOD TESTING, 2013
    • TABLE 32: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF INFLAMMATION BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • TABLE 33: LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN ONCOLOGY BLOOD TESTING, 2013
    • TABLE 34: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF ONCOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • TABLE 35: LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN TOXICOLOGY BLOOD TESTING, 2013
    • TABLE 36: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF TOXICOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013
    • TABLE 37: LEADING MANUFACTURERS/SUPPLIERS OF DEVICES, TEST STRIPS, AND ASSAYS IN OTHERS CATEGORY OF BLOOD TESTING, 2013
    • TABLE 38: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THE OTHERS CATEGORY OF BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • TABLE 39: GLOBAL REVENUE FOR BLOOD TESTS BY APPLICATION AND END USER, THROUGH 2019 ($ MILLIONS)
    • TABLE 40: MARKET SHARE OF BLOOD TESTS BY APPLICATION AND END USER, 2013 (%)
    • TABLE 41: GLOBAL REVENUE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, THROUGH 2019 ($ MILLIONS)
    • TABLE 42: MARKET SHARE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, 2013 (%)
    • TABLE 43: DIFFERENT KINDS OF CANCER
    • TABLE 44: CANCER BIOMARKERS
    • TABLE 45: GLOBAL REVENUE FOR CANCER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 46: BLOOD DISORDERS
    • TABLE 47: GLOBAL REVENUE FOR BLOOD DISORDER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 48: AUTOIMMUNE DISEASES
    • TABLE 49: GLOBAL REVENUE FOR AUTOIMMUNE DISEASE BLOOD TESTING AND FOOD ALLERGY BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 50: CARDIOVASCULAR DISEASES
    • TABLE 51: GLOBAL REVENUE FOR CARDIOVASCULAR DISEASE BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 52: KIDNEY DISORDERS
    • TABLE 53: GLOBAL REVENUE FOR KIDNEY DISORDER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 54: GLOBAL REVENUE FOR LIVER DISORDER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 55: INFECTIONS CAUSED BY MICROORGANISMS
    • TABLE 56: GLOBAL REVENUE FOR PREGNANCY BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 57: TYPES OF DIABETES
    • TABLE 58: GLOBAL REVENUE FOR DIABETES BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 59: GLOBAL REVENUE FOR FERTILITY BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 60: GLOBAL REVENUE FOR HOME-MONITORING BLOOD TESTING, THROUGH 2019 ($ MILLIONS)
    • TABLE 61: MARKET SHARE OF HOME-MONITORING BLOOD TESTING, 2013 (%)
    • TABLE 62: HOME-MONITORING DEVICES
    • TABLE 63: GLOBAL REVENUE FOR HOME-MONITORING DEVICES BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 64: GLOBAL REVENUE FOR HOME-MONITORING TEST STRIPS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 65: NUMBER OF SIGNIFICANT PATENTS BY YEAR, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • TABLE 66: NUMBER OF SIGNIFICANT PATENTS BY CATEGORY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • TABLE 67: NUMBER OF U.S. PATENTS BY COMPANY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • TABLE 68: NUMBER OF U.S. PATENTS BY COUNTRY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • TABLE 69: PATENT SHARES BY COUNTRY, JANUARY 2010 TO SEPTEMBER 2014 (%)
    • TABLE 70: NUMBER OF U.S. PATENTS BY ASSIGNEE, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL REVENUE FOR BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 1: GLOBAL REVENUE FOR BLOOD TESTS BY TYPE, 2012-2019 ($ MILLIONS)
    • FIGURE 2: MARKET SHARE OF BLOOD TESTS BY TYPE, 2013 (%)
    • FIGURE 3: GLOBAL REVENUE FOR BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 4: MARKET SHARE OF BLOOD TESTS BY REGION, 2013 (%)
    • FIGURE 5: GLOBAL REVENUE FOR HEMATOLOGY BLOOD TESTS BY TYPE, 2012-2019 ($ MILLIONS)
    • FIGURE 6: GLOBAL REVENUE FOR INFECTIOUS BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 7: GLOBAL REVENUE FOR BLOOD CLOTTING TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 8: GLOBAL REVENUE FOR COMPLETE BLOOD COUNT, COMPREHENSIVE BLOOD TESTS, AND ENZYME BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 9: GLOBAL REVENUE FOR CANCER/TUMOR ASSAY TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 10: GLOBAL REVENUE FOR TOXICOLOGY TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 11: GLOBAL REVENUE FOR HEART PROFILE BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 12: GLOBAL REVENUE FOR INFLAMMATION BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 13: GLOBAL REVENUE FOR OTHER BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 14: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEMATOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • FIGURE 15: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEART PROFILE BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • FIGURE 16: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF INFLAMMATION BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • FIGURE 17: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF ONCOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • FIGURE 18: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF TOXICOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • FIGURE 19: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THE OTHERS CATEGORY OF BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • FIGURE 20: GLOBAL REVENUE FOR BLOOD TESTS BY APPLICATION AND END USER, 2012-2019 ($ MILLIONS)
    • FIGURE 21: MARKET SHARE OF BLOOD TESTS BY APPLICATION AND END USER, 2013 (%)
    • FIGURE 22: GLOBAL REVENUE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, 2012-2019 ($ MILLIONS)
    • FIGURE 23: MARKET SHARE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, 2013 (%)
    • FIGURE 24: GLOBAL REVENUE FOR CANCER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 25: GLOBAL REVENUE FOR BLOOD DISORDER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 26: GLOBAL REVENUE FOR AUTOIMMUNE DISEASE BLOOD TESTING AND FOOD ALLERGY BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 27: GLOBAL REVENUE FOR CARDIOVASCULAR DISEASE BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 28: GLOBAL REVENUE FOR KIDNEY DISORDER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 29: GLOBAL REVENUE FOR LIVER DISORDER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 30: GLOBAL REVENUE FOR PREGNANCY BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 31: GLOBAL REVENUE FOR DIABETES BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 32: GLOBAL REVENUE FOR FERTILITY BLOOD TESTS, BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 33: GLOBAL REVENUE FOR HOME-MONITORING BLOOD TESTING, 2012-2019 ($ MILLIONS)
    • FIGURE 34: MARKET SHARE OF HOME-MONITORING BLOOD TESTING, 2013 (%)
    • FIGURE 35: GLOBAL REVENUE FOR HOME-MONITORING DEVICES BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 36: GLOBAL REVENUE FOR HOME-MONITORING TEST STRIPS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 37: NUMBER OF SIGNIFICANT PATENTS BY YEAR, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • FIGURE 38: NUMBER OF SIGNIFICANT PATENTS BY CATEGORY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • FIGURE 39: NUMBER OF U.S. PATENTS BY ASSIGNEE, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
Back to Top